LYEL short interest
Lyell Immunopharma Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 1,263,394 |
|---|---|
| Change vs prior report | 75,492 (+6.4%) |
| Change over six months | +11.0% |
| Days to cover | 7.40 (sector: 3.78) |
| Average daily volume | 170,775 |
| Rank in Healthcare | #218 of 922 by days to cover |
LYEL short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 1,263,394 | +6.4% | 7.40 | 170,775 |
| 2026-09-15 | 1,187,902 | +5.0% | 12.08 | 98,363 |
| 2026-08-31 | 1,131,628 | -1.7% | 8.89 | 127,223 |
| 2026-08-14 | 1,151,707 | -6.5% | 6.26 | 183,855 |
| 2026-07-31 | 1,231,583 | +0.9% | 8.66 | 142,256 |
| 2026-07-15 | 1,220,497 | -0.2% | 6.70 | 182,227 |
| 2026-06-30 | 1,223,220 | -7.1% | 3.44 | 355,339 |
| 2026-06-15 | 1,316,562 | -2.7% | 9.62 | 136,926 |
| 2026-05-29 | 1,353,275 | +1.0% | 16.21 | 83,489 |
| 2026-05-15 | 1,340,406 | -0.3% | 23.25 | 57,657 |
| 2026-04-30 | 1,344,189 | +8.9% | 18.78 | 71,577 |
| 2026-04-15 | 1,234,370 | +8.4% | 12.04 | 102,547 |
| 2026-03-31 | 1,138,296 | +21.1% | 12.78 | 89,076 |
| 2026-03-13 | 940,269 | +15.3% | 8.59 | 109,417 |
| 2026-02-27 | 815,248 | +37.7% | 7.63 | 106,872 |
| 2026-02-13 | 592,027 | +13.6% | 6.28 | 94,235 |
| 2026-01-30 | 521,115 | +27.9% | 6.09 | 85,589 |
| 2026-01-15 | 407,278 | +69.2% | 3.96 | 102,840 |
| 2025-12-31 | 240,730 | +46.4% | 1.58 | 152,163 |
| 2025-12-15 | 164,482 | +1.7% | 2.44 | 67,437 |
| 2025-11-28 | 161,792 | -0.8% | 3.35 | 48,226 |
| 2025-11-14 | 163,125 | -1.9% | 5.91 | 27,623 |
| 2025-10-31 | 166,193 | -9.6% | 6.54 | 25,429 |
| 2025-10-15 | 183,877 | -21.1% | 4.88 | 37,672 |
| 2025-09-30 | 233,067 | +43.3% | 2.60 | 89,521 |
import finzdata as yf
yf.Ticker("LYEL").short_interest # every report since 2017
yf.Client().short_interest(["LYEL"], start="2018-01-01")Healthcare short interest · LYEL price history · Who owns LYEL · All short interest